1. The Rationale for BAFF Inhibition in Systemic Lupus Erythematosus

   • Anne Davidson

   SYSTEMIC LUPUS ERYTHEMATOSUS (JT MERRILL, SECTION EDITOR) 26 April 2012 Pages: 295 - 302

   

2. Biologic Differences Between Various Inhibitors of the BLyS/BAFF Pathway: Should We Expect Differences Between Belimumab and Other Inhibitors in Development?

   • William Stohl

   SYSTEMIC LUPUS ERYTHEMATOSUS (JT MERRILL, SECTION EDITOR) 01 May 2012 Pages: 303 - 309

   

3. Belimumab and the Clinical Data

   • Katrina Shum
   • Anca Askanase

   SYSTEMIC LUPUS ERYTHEMATOSUS (JT MERRILL, SECTION EDITOR) 22 May 2012 Pages: 310 - 317

   

4. Belimumab Is Approved by the FDA: What More Do We Need to Know to Optimize Decision Making?

   • Diane Lewis Horowitz
   • Richard Furie

   SYSTEMIC LUPUS ERYTHEMATOSUS (JT MERRILL, SECTION EDITOR) 26 April 2012 Pages: 318 - 323

5. Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?

   • Marilyn C. Pike
   • Lexy Kelley

   SYSTEMIC LUPUS ERYTHEMATOSUS (JT MERRILL, SECTION EDITOR) Open access 13 May 2012 Pages: 324 - 333

   

6. Treatment Algorithms for Early Psoriatic Arthritis: Do They Depend on Disease Phenotype?

   • William Tillett
   • Neil McHugh

   PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS) 27 May 2012 Pages: 334 - 342

   

7. Cardiovascular Mortality in Psoriasis and Psoriatic Arthritis: Epidemiology, Pathomechanisms, Therapeutic Implications, and Perspectives

   • Wolf-Henning Boehncke
   • Sandra Boehncke

   PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS) 06 May 2012 Pages: 343 - 348

   

8. Altered Bone Biology in Psoriatic Arthritis

   • Homaira Rahimi
   • Christopher T. Ritchlin

   PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS) Open access 17 May 2012 Pages: 349 - 357

   

9. How Can Psoriatic Arthritis Be Diagnosed Early?

   • Amir Haddad
   • Vinod Chandran

   PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS) 11 May 2012 Pages: 358 - 363

10. What Have Genome-Wide Studies Told Us About Psoriatic Arthritis?

    • James Bluett
    • Anne Barton

    PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS) 25 April 2012 Pages: 364 - 368

    

11. Impact of Psoriatic Arthritis on the Patient: Through the Lens of the WHO International Classification of Functioning, Health, and Disability

    • William J. Taylor

    PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS) 17 May 2012 Pages: 369 - 374

    

12. Is Psoriatic Arthritis a Result of Abnormalities in Acquired or Innate Immunity?

    • Rik J. Lories
    • Kurt de Vlam

    PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS) 25 April 2012 Pages: 375 - 382